🐦 推特SerenityV1 · 实盘不做把握 5/10
北京时间·🕒 发布 04-21 01:37:36时区推断·⟳ 抓取 06-03 20:35:01回填·⚡ 决策 06-17 07:09:40·132.7 天前
KOL点评HIMS多肽业务与高做空比例，日内已涨8.6%
📄 原文Serenity↗ 原文
Looks like $HIMS is finally getting some attention, up +8.64% today. Peptide arc and acquisitions go brrr? Caught me by…
不做 HIMS.US
KOL盘面点评，无新实质性催化剂（多肽业务与收购为已知旧闻），日内已大涨8.6%，高做空比例(SI 36%)为持续状态而非突发变量，追高博弈逼空盈亏比不佳，缺乏明确edge。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
这条决策没有研究档案。
原文全文
展开原文 · 261 字
Looks like $HIMS is finally getting some attention, up +8.64% today.
Peptide arc and acquisitions go brrr?
Caught me by surprise why the SI is still 36% despite improving fundamentals.
I’m very curious to see how this all plays out with the longs vs. shorts.
Peptide arc and acquisitions go brrr?
Caught me by surprise why the SI is still 36% despite improving fundamentals.
I’m very curious to see how this all plays out with the longs vs. shorts.
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。